Equity Details
Price & Market Data
Price: $21.00
Daily Change: +$0.27 / 1.29%
Daily Range: $20.70 - $21.98
Market Cap: $28,163,940
Daily Volume: 27,876
Performance Metrics
1 Week: -18.79%
1 Month: -30.35%
3 Months: 138.1%
6 Months: 130.8%
1 Year: 189.4%
YTD: 96.81%
About Sensei Biotherapeutics, Inc. (SNSE)
In-depth market report for Sensei Biotherapeutics, Inc. (SNSE). The stock is valued at 21.00, with a daily change of +$0.27 / 1.29%. Market cap: 28,163,940. All key performance metrics are updated, including YTD and 52-week returns.
Company Details
Employees: 29
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.